Tandem Diabetes Care, Inc. (TNDM) News
Filter TNDM News Items
TNDM News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
TNDM News Highlights
- For TNDM, its 30 day story count is now at 19.
- Over the past 22 days, TNDM's stories per day has been in a clear uptrend, growing by about 0.19 per 2 days.
- The most mentioned tickers in articles about TNDM are GOLD, APP and BEAT.
Latest TNDM News From Around the Web
Below are the latest news stories about Tandem Diabetes Care Inc that investors may wish to consider to help them evaluate TNDM as an investment opportunity.
Tandem Diabetes Care, Inc. (TNDM) CEO John Sheridan on Q4 2021 Results - Earnings Call TranscriptTandem Diabetes Care, Inc. (TNDM) Q4 2021 Earnings Conference Call February 22, 2022, 04:30 PM ET Company Participants Susan Morrison - EVP and CAO John Sheridan - President and CEO Leigh Vosseller - EVP and CFO Brian Hansen - EVP and Chief Commercial Officer Conference Call Participants Chris Pasquale -... |
Tandem Diabetes (TNDM) Q4 Earnings Lag Estimates, Revenues TopRobust domestic and international pump shipments are driving Tandem Diabetes' (TNDM) fourth-quarter top line. |
Tandem Diabetes Care GAAP EPS of $0.16 misses by $0.06, revenue of $210M beats by $11.17MTandem Diabetes Care press release (NASDAQ:TNDM): Q4 GAAP EPS of $0.16 misses by $0.06. Revenue of $210M (+24.9% Y/Y) beats by $11.17M.... |
Tandem Diabetes up in after-hours trading despite missing on bottom lineShares of Tandem Diabetes Care (NASDAQ:TNDM) are up ~3% in after-hours trading even though the company missed on the bottom line in its Q4 2021 earnings. For 2022, sales are estimated to be in the range of $845M to $860M, which represents an annual sales growth of 20%-22% compared to 2021. Adjusted EBITDA is... |
Tandem Diabetes Care, Inc. (TNDM) Q4 Earnings Lag EstimatesTandem Diabetes Care, Inc. (TNDM) delivered earnings and revenue surprises of -20% and 6.08%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock? |
Tandem Diabetes Care Announces Fourth Quarter and Full Year 2021 Financial Results and 2022 Financial GuidanceSAN DIEGO, February 22, 2022--Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today reported its financial results for the quarter and year ended December 31, 2021 and financial guidance for the year ending December 31, 2022. |
Tandem Diabetes Care Q4 2021 Earnings PreviewTandem Diabetes Care (NASDAQ:TNDM) is scheduled to announce Q4 earnings results on Tuesday, February 22nd, after market close. The consensus EPS Estimate is $0.21 and the consensus Revenue Estimate is $198.83M (+18.3% Y/Y). Over the last 1 year, TNDM has beaten EPS estimates 75% of the time and has beaten... |
While shareholders of Tandem Diabetes Care (NASDAQ:TNDM) are in the black over 5 years, those who bought a week ago aren't so fortunateTandem Diabetes Care, Inc. ( NASDAQ:TNDM ) shareholders might be concerned after seeing the share price drop 21% in the... |
Tandem Diabetes (TNDM) to Offer Insulin Delivery With SmartphoneTandem Diabetes' (TNDM) t:connect is the first-ever app on both iOS and Android operating systems to receive FDA clearance for insulin delivery from a personal smartphone. |
Tandem Diabetes Care Announces FDA Clearance for the t:slim X2 Insulin Pump to Bolus Using the t:connect Mobile AppSAN DIEGO, February 16, 2022--Tandem Diabetes Care, Inc. announces FDA clearance of bolus insulin dosing on the t:slim X2 insulin pump using the t:connect mobile app. |